Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 2806 of 5804
-
New drug combo shows promise for Hard-to-Treat cancers
Disease control CompletedThis is a first-in-human, Phase I/II, open-label, multi-centre, dose escalation and expansion study to evaluate the safety, tolerability, pharmacokinetics, and preliminary anti-tumour activity of LM-108 as a single agent or in combination with an anti-PD-1 mAb in subjects with so…
Phase: PHASE1, PHASE2 • Sponsor: LaNova Australia Pty Limited • Aim: Disease control
Last updated Jun 26, 2026 15:31 UTC
-
New drug SKB315 targets hard-to-treat tumors in early trial
Disease control Recruiting nowThis is a multicenter, open-label, multiple-dose dose finding and expansion study to evaluate the safety, tolerability, pharmacokinetic(PK) profile, and anti-tumor efficacy of SKB315 for injection in patients with advanced solid tumors.
Phase: PHASE1 • Sponsor: Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:30 UTC
-
New pill could boost testosterone in men with kidney disease
Disease control Recruiting nowThis study in being conducted in men who have low testosterone and chronic kidney disease. The investigators will evaluate the effects of an oral testosterone preparation, JATENZO, on testosterone levels and hemoglobin (red blood cells).
Phase: PHASE2 • Sponsor: St. Louis University • Aim: Disease control
Last updated Jun 27, 2026 12:26 UTC
-
Gut health may boost bone density: probiotic study shows promise
Disease control CompletedOsteoporosis is a systemic condition characterized by low bone mass and altered bone tissue microarchitecture, with the resulting greater bone fragility leading to fractures. Osteoporosis develops as a result of genetic and environmental factors, with the patient's lifestyle play…
Phase: NA • Sponsor: Nordic Biotic Sp. z o.o. • Aim: Disease control
Last updated Jun 27, 2026 11:01 UTC
-
Daily pill could keep migraines at bay
Disease control CompletedThe purpose of this study is to further evaluate the long-term safety and tolerability of daily dosing of rimegepant for the prevention of episodic migraine.
Phase: PHASE4 • Sponsor: Pfizer • Aim: Disease control
Last updated Jun 26, 2026 12:46 UTC
-
Blood concentrate may boost healing of jaw bone damage from common drugs
Disease control CompletedMedication-Related Osteonecrosis of the Jaw (MRONJ) is a severe and increasingly prevalent clinical condition, defined as the presence of exposed mandibular or maxillary bone in the oral cavity persisting for at least eight weeks. The rising incidence of osteonecrosis of the jaw …
Phase: NA • Sponsor: Poznan University of Medical Sciences • Aim: Disease control
Last updated Jun 27, 2026 11:01 UTC
-
Magnetic pulses to the brain may ease autism social struggles
Symptom relief CompletedAutism spectrum disorder (ASD) encompasses a range of limitations in reciprocal social and communicative milestones, as well as restrictive and/or repetitive patterns of behavior which lead to significant functional challenges impacting individuals throughout their lifespan. Ther…
Phase: NA • Sponsor: Christiana Care Health Services • Aim: Symptom relief
Last updated Jun 27, 2026 08:00 UTC
-
Step-by-Step strategy aims to boost use of opioid addiction medications in clinics
Disease control CompletedThe purpose of this study is to expand access to medications for opioid use disorder (MOUD) in specialty addiction programs in Washington State. Sixty-four addiction treatment programs will participate in an adaptive implementation strategy trial that uses a stagewise implementat…
Phase: NA • Sponsor: Stanford University • Aim: Disease control
Last updated Jul 25, 2026 00:00 UTC
-
Exercise program aims to boost heart health in breast cancer survivors
Disease control Recruiting nowWomen with breast cancer who are referred to the cardiac rehabilitation program at the Toronto Rehabilitation Institute will be invited to enrol in this observational study. Participants will take part in an established 16-week multimodal cardiac rehabilitation program (HEALTh pr…
Sponsor: University of Toronto • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC
-
Brain subtypes may hold key to OCD treatment success
Knowledge-focused OngoingThe goal of this clinical trial is to discover brain-based subtypes of Obsessive Compulsive Disorder (OCD) and examine treatment response to two different repetitive transcranial magnetic stimulation (rTMS) targets in the brain: the medial prefrontal cortex (MPFC) and the right p…
Phase: NA • Sponsor: Stanford University • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:03 UTC
-
Virtual reality and music soothe burn patients during dressing changes
Symptom relief CompletedDifferent non-pharmacological methods such as virtual reality glasses and music can be applied by nurses within the scope of care interventions for the management of pain and anxiety in burn patients during dressing changes and debridement. In this study, it was aimed to determi…
Phase: NA • Sponsor: Karabuk University • Aim: Symptom relief
Last updated Jun 27, 2026 08:03 UTC
-
Blood test may spot hidden heart risk in kidney patients
Knowledge-focused OngoingArterial calcifications start at early stages of chronic kidney disease (CKD) and are associated to cardiovascular mortality. Pyrophosphate (PPi) is an endogenous compound, which stops the mineralization process in bones and is expected to act at ectopic sites. In uremic rats, lo…
Phase: NA • Sponsor: Centre Hospitalier Universitaire de Nice • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:35 UTC
-
New device zaps nose nerves to stop runny nose
Symptom relief CompletedThe CLARITY Study is a prospective, single-arm, multicenter safety and efficacy study of the Neurent Medical NEUROMARK System in subjects with chronic rhinitis.
Phase: NA • Sponsor: Neurent Medical • Aim: Symptom relief
Last updated Jun 27, 2026 13:05 UTC
-
New study aims to boost recovery for those with opioid and mental health struggles
Disease control Recruiting nowThis 4-year study will randomize 1,000 people with co-occurring opioid use and mental health disorders (COD) at medication for opioid use disorder (MOUD) clinics to evaluate the effectiveness of MISSION, a multi-component team approach, or its components with MOUD versus MOUD alo…
Phase: NA • Sponsor: University of Massachusetts, Worcester • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC
-
Home vs. clinic: which lymphedema therapy works best for cancer survivors?
Symptom relief OngoingThis randomized clinical trial aims to compare clinic-based CDT and home-based (a hybrid model) CDT on changes in the severity of lymphedema, symptom burden, functional status, and healthcare utilization in HNC survivors with lymphedema.
Phase: NA • Sponsor: Abramson Cancer Center at Penn Medicine • Aim: Symptom relief
Last updated Jun 27, 2026 12:29 UTC
-
New burn cream aims to speed healing in phase 2 trial
Symptom relief Recruiting nowTo compare MW-III to Silvadene® Cream 1% (Silver Sulfadiazine) with respect to "time to healing" (≥95% re-epithelialization) of a partial thickness target thermal burn.
Phase: PHASE2 • Sponsor: Skingenix, Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 11:01 UTC
-
New drug duo hopes to boost immune system against tough cancers
Disease control OngoingThe purpose of this study is to test the safety and tolerability of HFB200301 as a single agent and in combination with tislelizumab in patients with advanced cancers. There are two parts in this study. During the escalation part, groups of participants will receive increasing do…
Phase: PHASE1 • Sponsor: HiFiBiO Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
App-Based rehab for COPD: a breath of fresh air?
Disease control CompletedChronic obstructive pulmonary disease (COPD) is a public health problem: high prevalence; increasing morbidity and mortality; impact on health costs. Pulmonary rehabilitation (PR) is a multidisciplinary intervention combining exercise training, therapeutic education, psychosocial…
Phase: NA • Sponsor: University Hospital, Montpellier • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC
-
Zapping away dry mouth: new study tests Acupuncture-Like device for cancer survivors
Symptom relief Recruiting nowThe purpose of this study would like to learn if acupuncture-like electrical therapy can be used in patients with head and neck cancer who have had radiation treatment to treat dry mouth.
Phase: NA • Sponsor: University of Rochester • Aim: Symptom relief
Last updated Jun 26, 2026 15:41 UTC
-
Global study digs into immunotherapy success in kidney cancer
Knowledge-focused Recruiting nowThe ARON-1 Study is designed as an International Multicentric Retrospective Study to collect global experiences with the use of immuno-combinations in patients with metastatic RCC. Two Supplementary Studies (ARON-1α and ARON-1β) have been designed. The ARON-1α Supplementary Stud…
Sponsor: Hospital of Macerata • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:00 UTC